Drugging tRNA aminoacylation.

scientific article published on 18 January 2018

Drugging tRNA aminoacylation. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/15476286.2018.1429879
P932PMC publication ID6103670
P698PubMed publication ID29345185

P50authorJoanne M HoQ58442616
Dieter SöllQ88308803
P2093author name stringErol Bakkalbasi
Corwin A Miller
P2860cites workComplex ligand-induced conformational changes in tRNA(Asp) revealed by single-nucleotide resolution SHAPE chemistryQ46741203
MetalPDB in 2018: a database of metal sites in biological macromolecular structuresQ47118251
Toward a more complete view of tRNA biologyQ47652203
Twenty years of bacterial genome sequencingQ47916018
Active site titration and aminoacyl adenylate binding stoichiometry of aminoacyl-tRNA synthetasesQ52884162
The second genetic codeQ56772349
Species-specific differences in the operational RNA code for aminoacylation of tRNAProQ56902606
Relaxation of a transfer RNA specificity by removal of modified nucleotidesQ59058337
Kinetic techniques for the investigation of amino acid: tRNA ligases (aminoacyl-tRNA synthetases, amino acid activating enzymes)Q68695199
A single methyl group prevents the mischarging of a tRNAQ71955042
Inhibition of in vitro splicing of a group I intron of Pneumocystis cariniiQ72283603
Maintaining genetic code through adaptations of tRNA synthetases to taxonomic domainsQ74057435
Competitive inhibition of the acceptor activity of tRNA(Tyr II)(E. coli) by a combination of oligo G and a CCA terminated nineteen residue oligonucleotide of tRNA(Tyr II)(E. coli)Q77915299
THE EFFECT OF POLYNUCLEOTIDES ON AMINOACYL-RNA SYNTHETASES. 1. INHIBITION BY SYNTHETIC POLYNUCLEOTIDESQ78453082
Tavaborole topical solution (Kerydin) for onychomycosisQ95618242
Human phenylalanyl-tRNA synthetase: cloning, characterization of the deduced amino acid sequences in terms of the structural domains and coordinately regulated expression of the alpha and beta subunits in chronic myeloid leukemia cellsQ22008827
Aminoacyl-tRNA synthetases, the genetic code, and the evolutionary processQ24548515
Operational RNA code for amino acids: species-specific aminoacylation of minihelices switched by a single nucleotideQ24563104
On the evolution of structure in aminoacyl-tRNA synthetasesQ24597654
Recognition nucleotices for human phenylalanyl-tRNA synthetaseQ24630075
Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translationQ24649611
Pyrrolysine is not hardwired for cotranslational insertion at UAG codonsQ24685331
Visualizing bacterial tRNA identity determinants and antideterminants using function logos and inverse function logosQ25256728
Evolutionary Limitation and Opportunities for Developing tRNA Synthetase Inhibitors with 5-Binding-Mode ClassificationQ26775728
tRNAs as antibiotic targetsQ26822430
Distribution and frequencies of post-transcriptional modifications in tRNAsQ27302057
Insights into editing from an ile-tRNA synthetase structure with tRNAile and mupirocinQ27619361
Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNA(Val) and valyl-tRNA synthetaseQ27628915
Aminoglycoside binding displaces a divalent metal ion in a tRNA-neomycin B complexQ27632032
The structure of an AspRS-tRNA(Asp) complex reveals a tRNA-dependent control mechanismQ27634953
Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetaseQ27635179
Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetaseQ27641080
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing siteQ27646383
Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence for kingdom-specific design of the active sites and tRNA binding patternsQ27660193
Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphateQ27666287
The Double-Length Tyrosyl-tRNA Synthetase from the Eukaryote Leishmania major Forms an Intrinsically Asymmetric Pseudo-DimerQ27667299
ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetaseQ27675589
Structural dynamics of the aminoacylation and proofreading functional cycle of bacterial leucyl-tRNA synthetaseQ27681061
Plant tumour biocontrol agent employs a tRNA-dependent mechanism to inhibit leucyl-tRNA synthetaseQ27683856
Cocrystal Structures of Glycyl-tRNA Synthetase in Complex with tRNA Suggest Multiple Conformational States in GlycylationQ27684083
The Role of a Novel Auxiliary Pocket in Bacterial Phenylalanyl-tRNA Synthetase DruggabilityQ27684359
tRNA biology in mitochondriaQ28080757
Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistanceQ28138065
MODOMICS: a database of RNA modification pathways--2013 updateQ28278502
Facile Recoding of Selenocysteine in NatureQ36803248
Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition.Q37080420
A spectrophotometric assay for quantitative measurement of aminoacyl-tRNA synthetase activityQ37175880
An integrated, structure- and energy-based view of the genetic codeQ37294856
Is there a discriminator site in transfer RNA?Q37498225
Elucidating the druggable interface of protein-protein interactions using fragment docking and coevolutionary analysis.Q37515109
Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasitesQ37613101
Diversity and similarity in the tRNA world: overall view and case study on malaria-related tRNAsQ37636810
Deciphering synonymous codons in the three domains of life: co-evolution with specific tRNA modification enzymesQ37636818
Aminoacyl-tRNA synthetase inhibitors as potential antibiotics.Q37941955
Clinical relevance of the ESKAPE pathogensQ38086338
Ribosome-targeting antibiotics and mechanisms of bacterial resistance.Q38171225
Halofuginone - the multifaceted molecule.Q38311322
Biosynthesis and Function of Modified Bases in Bacteria and Their VirusesQ38869789
Genomics: Evolution of the Genetic CodeQ39346859
Binding of tobramycin leads to conformational changes in yeast tRNA(Asp) and inhibition of aminoacylationQ39646643
Aminoacyl tRNA synthetases: general scheme of structure-function relationships in the polypeptides and recognition of transfer RNAsQ39664914
Mechanism of bactericidal action of aminoglycosides.Q39675399
Universal rules and idiosyncratic features in tRNA identityQ39725604
The mechanism of aminoacylation of transfer RNA.Q39895857
The transfer RNA identity problem: a search for rulesQ40385593
Identity elements of human tRNA(Leu): structural requirements for converting human tRNA(Ser) into a leucine acceptor in vitroQ40395839
The exchange of the discriminator base A73 for G is alone sufficient to convert human tRNA(Leu) into a serine-acceptor in vitroQ40792478
Identity determinants of human tRNA(Ser): sequence elements necessary for serylation and maturation of a tRNA with a long extra arm.Q40873717
Aminoacyl-tRNA synthesis: divergent routes to a common goalQ41361752
tRNA(Phe) binds aminoglycoside antibioticsQ41697595
Purpuromycin: an antibiotic inhibiting tRNA aminoacylation.Q41830710
Functional analysis of human tRNA isodecodersQ41911424
Evidence that a major determinant for the identity of a transfer RNA is conserved in evolutionQ42073673
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetaseQ42881630
Identity of prokaryotic and eukaryotic tRNA(Asp) for aminoacylation by aspartyl-tRNA synthetase from Thermus thermophilusQ43023877
An example of non-conservation of oligomeric structure in prokaryotic aminoacyl-tRNA synthetases. Biochemical and structural properties of glycyl-tRNA synthetase from Thermus thermophilus.Q43024313
Aminoacyl tRNA synthetases as targets for new anti-infectives.Q46120262
Porphyrins and porphines bind strongly and specifically to tRNA, precursor tRNA and to M1 RNA and inhibit the ribonuclease P ribozyme reactionQ46591317
The RNA Modification Database, RNAMDB: 2011 updateQ28298150
tRNomics: analysis of tRNA genes from 50 genomes of Eukarya, Archaea, and Bacteria reveals anticodon-sparing strategies and domain-specific featuresQ28768508
The origin of the genetic codeQ29547681
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaQ29616084
tRNAdb 2009: compilation of tRNA sequences and tRNA genesQ29616661
Aminoacyl-tRNA synthesisQ29617527
Structure-based inhibition of protein-protein interactions.Q30367145
Computational analysis of tRNA identityQ30484326
Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetaseQ30636920
SerRS-tRNASec complex structures reveal mechanism of the first step in selenocysteine biosynthesisQ31814763
Synthetic inhibitors of the processing of pretransfer RNA by the ribonuclease P ribozyme: enzyme inhibitors which act by binding to substrateQ31914289
Quality control mechanisms during translationQ33785993
Evolution of aminoacyl-tRNA synthetases--analysis of unique domain architectures and phylogenetic trees reveals a complex history of horizontal gene transfer events.Q33870978
How antibiotics kill bacteria: from targets to networksQ33958766
Pentamidine inhibition of group I intron splicing in Candida albicans correlates with growth inhibitionQ33979139
Strategies for the Design of Drugs Targeting RNA and RNA-Protein ComplexesQ34001866
Summary: the modified nucleosides of RNA.Q34057777
General principles of antimicrobial therapyQ34161745
Human glycyl-tRNA synthetase. Wide divergence of primary structure from bacterial counterpart and species-specific aminoacylation.Q34325811
A new assay for tRNA aminoacylation kineticsQ34361503
Pentamidine inhibits mitochondrial intron splicing and translation in Saccharomyces cerevisiae.Q34362783
Novel insights of structure-based modeling for RNA-targeted drug discoveryQ34402678
Evolution of the tRNA(Tyr)/TyrRS aminoacylation systems.Q34451199
Robust Salmonella metabolism limits possibilities for new antimicrobials.Q34502598
The apicoplast: A plastid in Plasmodium falciparum and other apicomplexan parasitesQ34533262
Structure of human tryptophanyl-tRNA synthetase in complex with tRNATrp reveals the molecular basis of tRNA recognition and specificity.Q34541722
Novel classes of antibiotics or more of the same?Q34903245
Structure-based virtual screening for drug discovery: principles, applications and recent advances.Q35282223
Protein synthesis using a reconstituted cell-free systemQ35291142
A guide to ions and RNA structureQ35670060
tRNA acceptor stem and anticodon bases form independent codes related to protein foldingQ35764501
The identity of the discriminator base has an impact on CCA additionQ35770700
Methods for kinetic and thermodynamic analysis of aminoacyl-tRNA synthetasesQ36528700
Human tRNA(Gly) acceptor-stem microhelix: crystallization and preliminary X-ray diffraction analysis at 1.2 A resolutionQ36588420
Large Conformational Changes of Insertion 3 in Human Glycyl-tRNA Synthetase (hGlyRS) during CatalysisQ36674663
P433issue4-5
P304page(s)667-677
P577publication date2018-02-02
P1433published inRNA BiologyQ7277167
P1476titleDrugging tRNA aminoacylation
P478volume15

Reverse relations

cites work (P2860)
Q5539485511th IUBMB Focused Meeting on the Aminoacyl-tRNA Synthetases: Sailing a New Sea of Complex Functions in Human Biology and Disease.
Q59359256Aminoacyl-tRNA synthetases, therapeutic targets for infectious diseases
Q91304272Discovery of Small-Molecule Antibiotics against a Unique tRNA-Mediated Regulation of Transcription in Gram-Positive Bacteria
Q90609534Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines
Q57066430Lysine Acetylation Regulates Alanyl-tRNA Synthetase Activity in
Q90603856Mutations in ArgS arginine-tRNA synthetase confer additional antibiotic-tolerance protection to ESBL-producing Burkholderia thailandensis
Q89918999Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens
Q91748815Translational control of antibiotic resistance

Search more.